The Convergence of Biology and Technology: Enabling the Rise of Precision Medicine in Renal Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (15 May 2022) | Viewed by 2584
Special Issue Editors
Interests: systems biology; artificial intelligence; glomerulonephritis; kidney transplantation
Interests: genomics; transcriptomics; diabetic nephropathy; kidney transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There has been a vast increase in the availability of therapeutic options in every field of medicine. The bulk of such plurality of interventions represents a major advance toward personalized medicine. However, the ultimate goal of individualizing patient treatments can only be achieved through a granular dissection of the phenotype and the identification of molecular signatures that can aid in the optimization of the therapeutic intervention.
To this end, great effort must be put to integrate multiple data modalities comprising-omics, medical records, and imaging in order to provide actionable insights based on precise patient profiles. In this Special Issue of the Journal of Personalized Medicine, we aim at highlighting the results of such an approach that leverages the convergence of the most advanced techniques in biology and technology, to show the progresses that have been made toward precision medicine in the field of renal medicine. The issue will emphasize the relevance of these findings that encompass all areas of nephrology, from acute kidney injury and glomerulonephritis to transplantation.
Dr. Francesco Pesce
Guest Editor
Dr. Paola Pontrelli
Co-Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Kidney diseases
- Biomarkers
- Genomics
- Proteomics
- Transcriptomics
- Metabolomics
- Epigenetics
- Systems biology